Target & Activity
| Target | Activity | Value |
|---|---|---|
| p110δ | 1 nM | |
| p110α | 2 nM | |
| p110γ | 65 nM | |
| Vps34 | 110 nM | |
| p110β | 142 nM |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A549 | IC50 | 3.58 μM | Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay | [PMID: 32375077] |
| NCI-H1975 | IC50 | 0.94 μM | Antiproliferative activity against human NCI-H1975 cells harboring PIK3CA mutation assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay | [PMID: 32375077] |
| NCI-H460 | IC50 | 0.12 μM | Antiproliferative activity against human NCI-H460 cells harboring PIK3CA mutation assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay | [PMID: 32375077] |
| T47D | IC50 | 0.34 μM | Antiproliferative activity against human T47D cells harboring PIK3CA mutation assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay | [PMID: 32375077] |
| U-87MG ATCC | IC50 | 2.31 μM | Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay | [PMID: 32375077] |